Assessment of African Green Monkeys as a Large Animal Model for Hantavirus Infections
ID: HT9425-25-RFI-TJB-01Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT (AC13)

Original Source

https://sam.gov/opp/b130f6972dbd4eb1b38384b3aab92c50/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), is seeking information from qualified entities regarding the assessment of African Green Monkeys (AGM) as a large animal model for studying hantavirus infections. The objective is to establish the AGM as a viable model to enhance understanding of disease pathogenesis and to evaluate potential therapeutics for orthohantavirus infections, which pose significant biosecurity threats due to their high mortality rates and lack of current vaccines or treatments. Interested parties are invited to submit a Capability Statement detailing their relevant experience and expertise, with responses due by March 20, 2025, at 10:00 AM Eastern Time. For further inquiries, contact Tara Borntreger at tara.j.borntreger.civ@health.mil or Jeremy McMurry at jeremy.l.mcmurry.civ@health.mil.

    Point(s) of Contact
    Tara Borntreger
    tara.j.borntreger.civ@health.mil
    Jeremy McMurry
    jeremy.l.mcmurry.civ@health.mil
    Files
    No associated files provided.
    Similar Opportunities
    “Optimization of Aotus nancymaae non-human primate model for the development of multivalent Dengue vaccines using a self-amplifying RNA platform”.
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center, is seeking proposals for the optimization of the Aotus nancymaae non-human primate model to facilitate the development of multivalent Dengue vaccines utilizing a self-amplifying RNA platform. This procurement aims to enhance research and development efforts in the field of health, specifically targeting innovative vaccine solutions against Dengue fever. The project will be conducted in Peru, emphasizing the importance of advancing medical research in tropical diseases. Interested parties can reach out to Genaro Vasquez at genaro.m.vasquez.ln@health.mil or by phone at 0115116244128 for further details regarding the solicitation process.
    Bat Colony Husbandry
    Buyer not available
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with Colorado State University for the husbandry of bats. The contract entails housing and caring for bats in a specialized environment that meets the standards set by the American Zoological Association and the Animal Welfare Act, ensuring proper veterinary care and daily husbandry services. This initiative is crucial for ongoing long-term studies utilizing bat models, with the bats being maintained on-site at Colorado State University until needed for experiments. Interested parties capable of providing similar services may submit a capability statement to Diana Rohlman at diana.rohlman@nih.gov by 4:00 PM EST on March 22, 2025, as this is not a request for quotes.
    Solicitation HT942525R0037 - Human Subjects Protection Personnel Mgmt and Support Services - USAMRDC OHARO
    Buyer not available
    The Department of Defense, through the Army Medical Research Acquisition Activity, is soliciting proposals for Human Subjects Protection Personnel Management and Support Services under Solicitation HT942525R0037. The objective is to secure comprehensive personnel management and support tailored to Human Subjects Protection protocols, ensuring compliance with regulations and facilitating operational transitions for related services. This initiative is critical for enhancing research safety and ethics surrounding human subjects in studies and trials across various governmental contexts. Interested contractors should contact Alana M. Sowers at alana.m.sowers.civ@health.mil, with proposals due by March 26, 2025, as outlined in the solicitation documents.
    Scientific, Technical Research and Program Management Support Services for USAMRIID
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for scientific and technical research and program management support services for the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The procurement aims to enhance research capabilities in biotechnology, specifically focusing on health-related research and development services. This opportunity is critical for advancing the understanding and management of infectious diseases, thereby supporting national health security. Interested parties should note that this is an 8(a) set-aside contract, and inquiries can be directed to Christina Lewis at christina.m.lewis14.civ@health.mil or Jayme Fletcher at jayme.l.fletcher2.civ@health.mil.
    Aviation Services for Aerial Rabies Vaccine Dispersal
    Buyer not available
    The U.S. Department of Agriculture (USDA), through its Animal and Plant Health Inspection Service (APHIS), is soliciting proposals for a contract to provide commercial aviation services for the aerial dispersal of oral rabies vaccine (ORV) baits as part of the National Rabies Management Program (NRMP). The contract will encompass the provision of aircraft, qualified pilots, and operational support to effectively control rabies in wildlife populations across the eastern United States. This indefinite delivery indefinite quantity contract is set to commence on April 15, 2025, and will run through April 14, 2028, with a projected ceiling of $7.5 million. Interested contractors must submit proposals that include a quality control plan and demonstrate relevant technical capabilities, with evaluations based on price, past performance, and technical ability. For inquiries, interested parties can contact Amanda Barbosa at amanda.barbosa@usda.gov or by phone at 612-336-3433.
    RFI-ADVANCED MEDICAL MONITOR (AMM) DEVELOPMENT EFFORTS
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking industry input for the development of the Advanced Medical Monitor (AMM), which includes the Next Generation Medical Monitor (NGMM) and the Expeditionary Medical Monitor (EMM). This initiative aims to enhance non-invasive patient monitoring capabilities for military medical providers, particularly in response to the anticipated increase in casualties during large-scale combat operations. The AMM project is critical for improving real-time vital sign data and decision support, thereby facilitating better patient outcomes in combat zones. Interested parties are encouraged to submit their responses to the Request for Information (RFI) by contacting Jeanette Collins at jeanette.m.collins4.civ@health.mil or Kelly Green at kelly.r.green.civ@health.mil, with submissions due by the specified deadlines.
    Monoclonal Antibodies and Viral Recombinant Antigens
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking suppliers for monoclonal antibodies and viral recombinant antigens, as outlined in a Special Notice. This procurement aims to acquire in vitro diagnostic substances, reagents, test kits, and sets, which are critical for various medical and research applications within the military health system. The place of performance for this contract will be in Maryland, United States, and interested vendors can reach out to Shelley Wallace at shelley.a.wallace2.civ@health.mil or Tonya Kreps at tonya.r.kreps.civ@health.mil for further information. The notice does not specify a funding amount or key deadlines, but interested parties are encouraged to inquire for additional details.
    Brand Name or Equivalent of Bio-Rad Evolis and Geenius serological automated analyzers with UPS backup systems for the Walter Reed Army Institute of Research (WRAIR)
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking sources for the procurement of Bio-Rad Evolis and Geenius serological automated analyzers, along with uninterrupted power supply (UPS) backup systems, for the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland. The requirement includes high-volume HIV testing and confirmation capabilities, with specifications for independent processing systems, automated sample integrity detection, and compatibility with existing laboratory systems, all while adhering to FDA regulations for HIV screening. This initiative is crucial for enhancing infectious disease management among U.S. service members, particularly concerning HIV and hepatitis C. Interested vendors should contact Brenda Mena at brenda.i.mena.civ@health.mil or Sharew Hailu at sharew.hailu.civ@health.mil for further details, as the contract is expected to span from September 30, 2025, to September 29, 2030.
    Request for Information (RFI) for Device and Maintenance Services for medical point-of-care molecular disease analyzer.
    Buyer not available
    The Department of Homeland Security, specifically the U.S. Coast Guard (USCG), is issuing a Request for Information (RFI) to explore the market for medical point-of-care molecular disease analyzers, with the intent to replace its aging Cepheid GeneXpert systems. The USCG aims to procure approximately 55 new devices that can test for multiple diseases, including SARS-CoV-2, Influenza A and B, and various bacterial infections, emphasizing the need for FDA approval, high specificity and sensitivity, rapid turnaround times within 60 minutes, and compatibility with electronic health records. This initiative is crucial for enhancing the USCG's medical capabilities and ensuring timely disease detection among personnel. Interested vendors are encouraged to submit their responses by March 25, 2025, and can direct inquiries to Jamison Harned at jamison.w.harned@uscg.mil or by phone at 571-613-5151.
    NIAID Virology Quality Assurance
    Buyer not available
    The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals for the Virology Quality Assurance (VQA) program under RFP number 75N93024R00030, aimed at enhancing quality assessment for virologic testing in clinical trials related to HIV and other viral pathogens. The program requires contractors to provide comprehensive quality assurance services, including performance validation reports and progress updates, while adhering to strict federal regulations and ethical standards concerning human subjects in research. This initiative is critical for establishing robust quality controls in virology testing, thereby supporting public health responses and ongoing research efforts. Proposals are due by April 8, 2025, at 3:00 PM EST, and interested parties should direct inquiries to Shawnice Williams at shawnice.williams@nih.gov or Ashley Kinderdine at ashley.kinderdine@nih.gov for further clarification.